193
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Systemic Inflammatory Response Syndrome on Admission and Clinical Outcomes After Intracerebral Hemorrhage

ORCID Icon, , ORCID Icon, , , ORCID Icon & show all
Pages 917-926 | Received 24 Oct 2022, Accepted 18 Feb 2023, Published online: 02 Mar 2023

References

  • Shi KB, Tian DC, Li ZLG, Ducruet AF, Lawton MT, Shi FD. Global brain inflammation in stroke. Lancet Neurol. 2019;18(11):1058–1066. doi:10.1016/S1474-4422(19)30078-X
  • Saand AR, Yu F, Chen J, Chou SHY. Systemic inflammation in hemorrhagic strokes - a novel neurological sign and therapeutic target? J Cereb Blood Flow Metab. 2019;39(6):959–988. doi:10.1177/0271678X19841443
  • Durocher M, Ander BP, Jickling G, et al. Inflammatory, regulatory, and autophagy co-expression modules and hub genes underlie the peripheral immune response to human intracerebral hemorrhage. J Neuroinflamm. 2019;16. doi:10.1186/s12974-019-1433-4
  • Gusdon AM, Thompson CB, Quirk K, et al. CSF and serum inflammatory response and association with outcomes in spontaneous intracerebral hemorrhage with intraventricular extension: an analysis of the CLEAR-III trial. J Neuroinflamm. 2021;18(1). doi:10.1186/s12974-021-02224-w
  • Li W, Li LL, Li WK, et al. Spleen associated immune-response mediates brain-heart interaction after intracerebral hemorrhage. Exp Neurol. 2020;327:113209.
  • Chen ZL, Venkat P, Seyfried D, Chopp M, Yan T, Chen JL. Brain-heart interaction cardiac complications after stroke. Circ Res. 2017;121(4):451–468. doi:10.1161/CIRCRESAHA.117.311170
  • Eltringham SA, Kilner K, Gee M, et al. Impact of dysphagia assessment and management on risk of stroke-associated pneumonia: a systematic review. Cerebrovasc Dis. 2018;46(3–4):97–105. doi:10.1159/000492730
  • Kalita J, Bastia J, Bhoi SK, Misra UK. Systemic inflammatory response syndrome predicts severity of stroke and outcome. J Stroke Cerebrovasc. 2015;24(7):1640–1648. doi:10.1016/j.jstrokecerebrovasdis.2015.03.057
  • Jafari M, Katlowitz K, De la Garza C, et al. Impact of systemic inflammatory response syndrome on acute ischemic stroke patients treated with mechanical thrombectomy. J Neurol Sci. 2021;430:119988. doi:10.1016/j.jns.2021.119988
  • Xu XJ, Yuan LL, Wang WB, et al. Systemic inflammatory response syndrome and outcomes in ischemic patients treated with endovascular treatment. Clin Interv Aging. 2020;15:2331–2340. doi:10.2147/CIA.S281865
  • Boehme AK, Kapoor N, Albright KC, et al. Systemic inflammatory response syndrome in tissue-type plasminogen activator-treated patients is associated with worse short-term functional outcome. Stroke. 2013;44(8):2321–2323. doi:10.1161/STROKEAHA.113.001371
  • Yoshimoto Y, Tanaka Y, Hoya K. Acute systemic inflammatory response syndrome in subarachnoid hemorrhage. Stroke. 2001;32(9):1989–1993. doi:10.1161/hs0901.095646
  • Boehme AK, Hays AN, Kicielinski KP, et al. Systemic inflammatory response syndrome and outcomes in intracerebral hemorrhage. Neurocrit Care. 2016;25(1):133–140. doi:10.1007/s12028-016-0255-9
  • Hagen M, Sembill JA, Sprugel MI, et al. Systemic inflammatory response syndrome and long-term outcome after intracerebral hemorrhage. Neurol-Neuroimmunol. 2019;6(5). doi:10.1212/NXI.0000000000000588
  • Melmed KR, Carroll E, Lord AS, et al. Systemic inflammatory response syndrome is associated with hematoma expansion in intracerebral hemorrhage. J Stroke Cerebrovasc. 2021;30(8):105870.
  • Boehme AK, Comeau ME, Langefeld CD, et al. Systemic inflammatory response syndrome, infection, and outcome in intracerebral hemorrhage. Neurol-Neuroimmunol. 2018;5(2). doi:10.1212/NXI.0000000000000428
  • Kothari U, Brott T, Broderick JP, et al. The ABCs of measuring intracerebral hemorrhage volumes. Stroke. 1996;27(8):1304–1305. doi:10.1161/01.STR.27.8.1304
  • Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES. The sympathetic nerve - an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev. 2000;52(4):595–638.
  • Guterman EL, Kamel H, Azran C, et al. Time from onset of SIRS to antibiotic administration and outcomes after subarachnoid hemorrhage. Neurocrit Care. 2014;21(1):85–90. doi:10.1007/s12028-013-9846-x
  • Di Napoli M, Behrouz R, Topel CH, et al. Hypoalbuminemia, systemic inflammatory response syndrome, and functional outcome in intracerebral hemorrhage. J Crit Care. 2017;41:247–253. doi:10.1016/j.jcrc.2017.06.002
  • Mijajlovic MD, Pavlovic A, Brainin M, et al. Post-stroke dementia - a comprehensive review. BMC Med. 2017;15. doi:10.1186/s12916-017-0779-7
  • Elkins J, Veltkamp R, Montaner J, et al. Safety and efficacy of natalizumab in patients with acute ischaemic stroke (ACTION): a randomised, placebo-controlled, double-blind Phase 2 trial. Lancet Neurol. 2017;16(3):217–226. doi:10.1016/S1474-4422(16)30357-X
  • Fish EN. The X-files in immunity: sex-based differences predispose immune responses. Nat Rev Immunol. 2008;8(9):737–744. doi:10.1038/nri2394
  • Marini S, Morotti A, Lena UK, et al. Men experience higher risk of pneumonia and death after intracerebral hemorrhage. Neurocrit Care. 2018;28(1):77–82. doi:10.1007/s12028-017-0431-6
  • Agnihotri S, Staff I, Fortunato G, Czap A, McCullough L. Peripheral leukocyte counts and outcomes after intracerebral hemorrhage. Neurology. 2011;76(9):A152–A152.
  • Morotti A, Phuah CL, Anderson CD, et al. Leukocyte count and intracerebral hemorrhage expansion. Stroke. 2016;47(6):1473–1478. doi:10.1161/STROKEAHA.116.013176
  • Miwa K, Koga M, Fukuda-Doi M, et al. Effect of heart rate variabilities on outcome after acute intracerebral hemorrhage: a post hoc analysis of ATACH-2. J Am Heart Assoc. 2021;10(16). doi:10.1161/JAHA.120.020364
  • Hervella P, Rodriguez-Yanez M, Pumar JM, et al. Antihyperthermic treatment decreases perihematomal hypodensity. Neurology. 2020;94(16):E1738–E1748. doi:10.1212/WNL.0000000000009288
  • Shi K, Zhang J, Li Z, Li M, Shi FD. Organ- and cell-specific immune responses are associated with the outcomes of intracerebral hemorrhage. Eur J Immunol. 2019;49:1456–1457.
  • Li YJ, Chang GQ, Liu YC, et al. Fingolimod alters inflammatory mediators and vascular permeability in intracerebral hemorrhage. Neurosci Bull. 2015;31(6):755–762. doi:10.1007/s12264-015-1532-2
  • Lee SH, Park HK, Ryu WS, et al. Effects of celecoxib on hematoma and edema volumes in primary intracerebral hemorrhage: a multicenter randomized controlled trial. Eur J Neurol. 2013;20(8):1161–1169. doi:10.1111/ene.12140
  • Liu Y, Li Z, Khan S, et al. Neuroprotection of minocycline by inhibition of extracellular matrix metalloproteinase inducer expression following intracerebral hemorrhage in mice. Neurosci Lett. 2021;764:136297. doi:10.1016/j.neulet.2021.136297
  • Yang H, Gao X, Xiao W, et al. Minocycline alleviates white matter injury following intracerebral hemorrhage by regulating CD4(+) T cell differentiation via Notch1 signaling pathway. Oxid Med Cell Longev. 2022;2022:3435267. doi:10.1155/2022/3435267
  • Fu Y, Hao J, Zhang N, et al. Fingolimod for the treatment of intracerebral hemorrhage: a 2-arm proof-of-concept study. JAMA Neurol. 2014;71(9):1092–1101. doi:10.1001/jamaneurol.2014.1065